CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

PTHSPelthos Therapeutics Inc.

AMEX · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close $20.35 · 2026-10-01
ABOUT
ExchangeAMEX
SectorHealthcare
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap$80.44M
CountryUSA
RECENT INSIDER TRADES
  • 2026-10-06 · Greenleaf Peter (Director) · SELL
  • 2026-10-06 · Pauls Matthew (Director) · SELL
  • 2026-10-06 · Friedberg Ezra M (Director) · SELL
  • 2026-07-07 · Friedberg Ezra M (Director) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders25
Shares held1,398,183
Value$39.72M
Percent of shares outstanding36.52%
As of quarter end2026-06-30
RECENT NEWS
  • Pelthos Therapeutics director Peter Greenleaf sells $16,872 in stock
  • Pelthos Therapeutics director sells $11,560 in common stock
  • Pelthos Therapeutics director Matthew Pauls sells $16,506 in shares
  • Pelthos Therapeutics Announces Expanded Formulary Coverage for ZELSUVMI® (berdazimer) Topical Gel, 10.3%
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS